Search by Drug Name or NDC

    NDC 00591-4730-30 Deferasirox 90 mg/1 Details

    Deferasirox 90 mg/1

    Deferasirox is a ORAL GRANULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is DEFERASIROX.

    Product Information

    NDC 00591-4730
    Product ID 0591-4730_5a3a827b-be6c-4d85-8cae-2e974101d7f2
    Associated GPIs
    GCN Sequence Number 077441
    GCN Sequence Number Description deferasirox GRAN PACK 90 MG ORAL
    HIC3 C8A
    HIC3 Description METALLIC POISON,AGENTS TO TREAT
    GCN 43449
    HICL Sequence Number 033337
    HICL Sequence Number Description DEFERASIROX
    Brand/Generic Generic
    Proprietary Name Deferasirox
    Proprietary Name Suffix n/a
    Non-Proprietary Name Deferasirox
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GRANULE
    Route ORAL
    Active Ingredient Strength 90
    Active Ingredient Units mg/1
    Substance Name DEFERASIROX
    Labeler Name Actavis Pharma, Inc.
    Pharmaceutical Class Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214180
    Listing Certified Through 2024-12-31

    Package

    NDC 00591-4730-30 (00591473030)

    NDC Package Code 0591-4730-30
    Billing NDC 00591473030
    Package 30 PACKET in 1 CARTON (0591-4730-30) / 1 GRANULE in 1 PACKET (0591-4730-54)
    Marketing Start Date 2023-11-10
    NDC Exclude Flag N
    Pricing Information N/A